Last checked at 25 Jul 2014 05:11
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Hutchmed Share News (HCM)
HCM Share
Price
HCM Share
News
HCM Share
Chat
HCM Share
Trades7
HCM
Live RNS
HCM Share
Charts
HCM Level 2
Console
HCM Live
Share Price
HCM Broker
Ratings
HCM Directors
Deals
HCM Financial
Diary
HCM
Fundamentals
HCM Short
Positions
HCM
Media
Hutchmed Information
Share Price Information for Hutchmed (HCM)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
294.00
Bid:
292.00
Ask:
298.00
Change:
-3.00 (-1.01%)
Spread:
6.00 (2.055%)
Open:
294.00
High:
294.00
Low:
294.00
Prev. Close:
298.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.24 Jul 2014 15:43
24 Jul 2014 05:08
23 Jul 2014 15:12
23 Jul 2014 05:39
22 Jul 2014 15:37
22 Jul 2014 15:14
25 Jun 2014 10:42
18 Jun 2014 07:47
Hutchinson China MediTech Starts HMPL-523 Trial For Autoimmune Disease
LONDON (Alliance News) - Hutchison China MediTech Ltd said Wednesday its majority owned research and development company has begun the first in-human Phase I clinical trial of HMPL-523 for autoimmune diseases. Hutchinson MediPharma Ltd has begun the trial in Australia, with the aim of estab
Read more5 Jun 2014 11:22
Hutchinson China MediTech Launches Phase II Lung Cancer Drug Trial
LONDON (Alliance News) - Hutchinson China MediTech Ltd said Thursday that its majority owned research and development company has begun a Phase II clinical trial of drug fruquintinib for the treatment of non-small cell lung cancer in China. The trial is targeted at patients who have failed
Read more4 Jun 2014 13:39
DIRECTOR DEALINGS: Hutchinson China MediTech Non-Executive Buys Shares
LONDON (Alliance News) - Hutchinson China MediTech Ltd said Wednesday that Independent Non-Executive Director Christopher Nash bought 4,036 shares at 842 pence each. Following this transaction, Nash's interest in the China-based healthcare company is 0.06%. Shares in China MediTech we
Read more30 May 2014 08:37
Hutchison China MediTech's JV Gets Rights To Six Drugs From Partner
LONDON (Alliance News) - Hutchison China MediTech Ltd Friday said Shanghai Traditional Chinese Medicine Co. Ltd has decided to grant the two companies' joint venture exclusive rights to sell six prescription drug products in China. In a statement, Chi-Med said the Shanghai Hutchison Pharmac
Read more23 May 2014 11:28
Hutchison China And AstraZeneca Partner For Kidney Cancer Study
LONDON (Alliance News) - Hutchison China MediTech Ltd Friday said its research and development company Hutchison MediPharma Ltd and pharmaceuticals firm AstraZeneca PLC have initiated a global phase II study to evaluate the efficacy and safety of AZD6094, Hutchison's potent and highly selective c
Read more19 May 2014 07:55
Monday broker round-up UPDATE
Alent: Numis moves target price from 330p to 340p upgrading to add. AVEVA Group: Westhouse Securities initiates with a target price of 2260p and a buy recommendation. Bovis Homes Group: Deutsche Bank shifts target price from 1039p to 1042p and stays with its buy recommendation. Brown (N) Group: J
Read more8 May 2014 07:29
UK MORNING BRIEFING: UK Shares Open Higher, Led By BT And Barclays
LONDON (Alliance News) - UK shares have opened mostly higher Thursday ahead of interest-rate decisions by the Bank of England and European Central Bank and amid tentative signs of reduced tensions in Ukraine.
BT and Barclays lead the FTSE 100 at the